GXP PHARMAID ApS
CVR 29615861 · Private limited company (ApS) · Active · Low risk
GXP PHARMAID ApS is a Private limited company (ApS), founded on , based in Brønshøj. The company is registered in the industry anden teknisk rådgivning. Our model estimates a bankruptcy risk of 0.2% over the next 12 months, which is 0.2 times the average for Danish companies. 19 annual reports have been published, of which 5 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 1.2m and a net result of DKK 122k. CEO: Nusret Asanovski.
Bankruptcy risk for GXP PHARMAID ApS
0.2 × the average (1.41%) · higher risk than 49% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 29615861
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (20 years)
- Address
- Korsager Allé 9
2700 Brønshøj - Municipality
- København
- Industry
- Anden teknisk rådgivning (711290)
Bankruptcies in the industry: Rådgivende ingeniørvirksomhed inden for byggeri og anlægsarbejder - Share capital
- DKK 125k
- Employees
- 2 (2018)
- Auditor
- AIDER Godkendt Revisionsaktieselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 5 of 19 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 66.7% |
| Current ratio | 300% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 2 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK 1.2m | DKK 1.3m |
| Net profit | DKK 122k | DKK 217k |
| Equity | DKK 1.2m | DKK 1.1m |
| Total assets | DKK 1.8m | DKK 1.8m |
| Cash | DKK 596k | – |
| Short-term debt | DKK 608k | – |
| Avg. employees | 1 | – |
Latest annual report: Reporting class B · auditor's statement: Erklæring om udvidet gennemgang · Baker Tilly Denmark.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 188 | Late | |
| 1 Jan 2024 – 31 Dec 2024 | 181 | ||
| 1 Jan 2023 – 31 Dec 2023 | 183 | ||
| 1 Jan 2022 – 31 Dec 2022 | 195 | Late | |
| 1 Jan 2021 – 31 Dec 2021 | 185 | Late | |
| 1 Jan 2020 – 31 Dec 2020 | 172 | ||
| 1 Jan 2019 – 31 Dec 2019 | 219 | Late | |
| 1 Jan 2018 – 31 Dec 2018 | 168 | ||
| 1 Jan 2017 – 31 Dec 2017 | 151 | ||
| 1 Jan 2016 – 31 Dec 2016 | 129 | ||
| 1 Jan 2015 – 31 Dec 2015 | 116 | ||
| 1 Jan 2014 – 31 Dec 2014 | 159 | ||
| 1 Jan 2013 – 31 Dec 2013 | 168 | ||
| 1 Jan 2012 – 31 Dec 2012 | 151 | ||
| 1 Jan 2011 – 31 Dec 2011 | 161 | ||
| 1 Jan 2010 – 31 Dec 2010 | 157 | ||
| 1 Jan 2009 – 31 Dec 2009 | 172 | ||
| 1 Jan 2008 – 31 Dec 2008 | 159 | ||
| 23 May 2006 – 30 Jun 2007 | 288 | Late |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Nusret Asanovski | Current | |
| Board | Nusret Asanovski | ||
| Board | Jonas Evjenios Markou | ||
| Board | Mogens Birch-Larsen | ||
| Owner (100%) | MAC ANDORBY ApS | Current | |
| Auditor | AIDER Godkendt Revisionsaktieselskab | Current | |
| Auditor | LST DK Holding ApS | ||
| Auditor | TIMEVISION FREDERIKSBERG GODKENDT REVISIONSAKTIESELSKAB | ||
| Auditor | EMIT P/S | ||
| Founder | Nusret Asanovski | Current |
The CEOs' other companies
Nusret Asanovski – 2 other companies
- MAC ANDORBY ApS Active
- Mindtilus ApS Active
Address history (3 moves)
| Korsager Allé 9, 2700 Brønshøj | |
| Kobbelvænget 74, 1., 2700 Brønshøj | |
| Fruebjergvej 3, 2100 København Ø | |
| c/o Nusret Asanovski, Korsager Allé 9, 2700 Brønshøj |
Former names
| GXP PHARMAID ApS | – now |
| Q-VIGILANCE ApS | – |
Employees per year
Other companies at the same address
- MAC ANDORBY ApS Active
- Mindtilus ApS Active
Similar companies in København
- BOBACH ApS København K
- SCANDINAVIAN JOINT SHIPPING SERVICE ApS København Ø
- Saka Energy Consulting Aps Vanløse
- Forberedt ApS København S
- LUMAIQ Lysteknik ApS København NV
- Navitas-Consult ApS København S
- Enectrify ApS Hellerup
- Paebbl Denmark ApS København Ø
- SHB Legacy ApS København S
- Equus Energy Systems ApS København NV
- PR Tryghed ApS København Ø
- Nunchi Climate Group ApS Brønshøj
Questions and answers about GXP PHARMAID ApS
Has GXP PHARMAID ApS gone bankrupt?
No, GXP PHARMAID ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of GXP PHARMAID ApS?
Our model estimates a bankruptcy risk of 0.2% over the next 12 months (low risk), which is 0.2 times the average for Danish companies.
Who is the CEO of GXP PHARMAID ApS?
Nusret Asanovski is the CEO of GXP PHARMAID ApS.
Who is the auditor of GXP PHARMAID ApS?
GXP PHARMAID ApS most recently used AIDER Godkendt Revisionsaktieselskab.
When was GXP PHARMAID ApS founded?
GXP PHARMAID ApS was founded on 23 May 2006.
What is the equity of GXP PHARMAID ApS?
Equity was DKK 1.2m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.